Cong Hu

603 total citations
21 papers, 442 citations indexed

About

Cong Hu is a scholar working on Immunology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Cong Hu has authored 21 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Complementary and alternative medicine. Recurrent topics in Cong Hu's work include Immune cells in cancer (5 papers), Reproductive System and Pregnancy (4 papers) and Natural Compounds in Disease Treatment (3 papers). Cong Hu is often cited by papers focused on Immune cells in cancer (5 papers), Reproductive System and Pregnancy (4 papers) and Natural Compounds in Disease Treatment (3 papers). Cong Hu collaborates with scholars based in China, Ethiopia and Saudi Arabia. Cong Hu's co-authors include Huanfa Yi, Bo Pang, Zhen Yu, Zhanchuan Ma, Yiyang Li, Hua Song, Hongmei Xu, Jie Hou, Zhonggao Xu and Shan Lin and has published in prestigious journals such as Blood, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Cong Hu

19 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cong Hu China 14 184 152 108 56 31 21 442
Suneetha Amara United States 12 167 0.9× 103 0.7× 78 0.7× 86 1.5× 12 0.4× 23 424
Sisi Wei China 12 313 1.7× 74 0.5× 150 1.4× 56 1.0× 27 0.9× 49 492
Xiaoming Huang China 14 329 1.8× 107 0.7× 166 1.5× 119 2.1× 29 0.9× 54 616
Wenzhen Dang China 12 214 1.2× 92 0.6× 41 0.4× 51 0.9× 29 0.9× 15 402
Haizhao Yan China 12 265 1.4× 82 0.5× 92 0.9× 66 1.2× 13 0.4× 28 551
Haibing Wang China 11 294 1.6× 85 0.6× 44 0.4× 59 1.1× 30 1.0× 25 433

Countries citing papers authored by Cong Hu

Since Specialization
Citations

This map shows the geographic impact of Cong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Hu more than expected).

Fields of papers citing papers by Cong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Hu. The network helps show where Cong Hu may publish in the future.

Co-authorship network of co-authors of Cong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Cong Hu. A scholar is included among the top collaborators of Cong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong Hu. Cong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qin, Yang, Yinghong Zhu, Xingxing Jian, et al.. (2024). Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma. Blood. 145(17). 1876–1889.
3.
Hu, Cong, et al.. (2023). Coenzyme Q10 Stimulate Reproductive Vatality. Drug Design Development and Therapy. Volume 17. 2623–2637. 12 indexed citations
4.
Jiang, Dahai, Jun Xu, Liping Deng, et al.. (2023). Three-stage fermentation of the feed and the application on weaned piglets. Frontiers in Veterinary Science. 10. 1123563–1123563. 5 indexed citations
5.
6.
Hu, Cong, Zhen Yu, Zhanchuan Ma, et al.. (2022). Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression. Molecular Therapy. 31(2). 569–584. 13 indexed citations
7.
Lin, Lanlan, et al.. (2021). ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway. Cancer Cell International. 21(1). 320–320. 10 indexed citations
8.
Hu, Cong, et al.. (2020). <p>Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis</p>. Drug Design Development and Therapy. Volume 14. 4659–4670. 9 indexed citations
9.
Zhang, Zhihong, et al.. (2020). <p>Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis</p>. OncoTargets and Therapy. Volume 13. 6651–6660. 17 indexed citations
10.
Ma, Zhanchuan, Yan Xia, Cong Hu, Miaomiao Yu, & Huanfa Yi. (2020). Quercetin promotes the survival of granulocytic myeloid-derived suppressor cells via the ESR2/STAT3 signaling pathway. Biomedicine & Pharmacotherapy. 125. 109922–109922. 14 indexed citations
11.
Han, Jiawen, et al.. (2020). <p>Prediction of Targets of Curculigoside A in Osteoporosis and Rheumatoid Arthritis Using Network Pharmacology and Experimental Verification</p>. Drug Design Development and Therapy. Volume 14. 5235–5250. 37 indexed citations
12.
Hu, Cong, et al.. (2020). Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer. Journal of Cancer Research and Clinical Oncology. 146(6). 1415–1426. 28 indexed citations
13.
Pang, Bo, Zhen Yu, Cong Hu, et al.. (2020). Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway. Clinical Science. 134(16). 2209–2222. 46 indexed citations
14.
Ma, Zhanchuan, Zhen Yu, Cong Hu, & Huanfa Yi. (2020). Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice. Frontiers in Immunology. 11. 687–687. 26 indexed citations
15.
Hu, Cong, et al.. (2019). Myeloid-Derived Suppressor Cells Are Regulated by Estradiol and Are a Predictive Marker for IVF Outcome. Frontiers in Endocrinology. 10. 521–521. 19 indexed citations
16.
Hu, Cong, et al.. (2019). Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells. British Journal of Cancer. 122(1). 23–29. 59 indexed citations
17.
Hu, Cong, et al.. (2019). Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p. Bioscience Reports. 39(5). 22 indexed citations
18.
Hu, Xiaobo, Cong Hu, Caiping Zhang, et al.. (2019). Role of Adiponectin in prostate cancer. International braz j urol. 45(2). 220–228. 27 indexed citations
19.
Pan, Yuan, Liqun Zhang, Xinyue Zhang, Cong Hu, & Ruizhi Liu. (2016). Biological and biomechanical analysis of two types of mesenchymal stem cells for intervention in chemotherapy-induced ovarian dysfunction. Archives of Gynecology and Obstetrics. 295(1). 247–252. 13 indexed citations
20.
Xu, Hongmei, et al.. (2016). Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway. Journal of Physiology and Biochemistry. 72(4). 721–732. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suneetha Amara Breakdown of academic impact, for papers by Sisi Wei Breakdown of academic impact, for papers by Xiaoming Huang Breakdown of academic impact, for papers by Wenzhen Dang Breakdown of academic impact, for papers by Haizhao Yan Breakdown of academic impact, for papers by Haibing Wang
Rankless by CCL
2026